Leishmania is exposed to a sudden increase in environmental temperature during the infectious cycle that triggers stage differentiation and adapts the parasite phenotype to intracellular survival in the mammalian host. The absence of classical promoter-dependent mechanisms of gene regulation and constitutive expression of most of the heat-shock proteins (HSPs) in these human pathogens raise important unresolved questions as to regulation of the heat-shock response and stage-specific functions of Leishmania HSPs. Here we used a gel-based quantitative approach to assess the Leishmania donovani phosphoproteome and revealed that 38% of the proteins showed significant stage-specific differences, with a strong focus of amastigote-specific phosphoproteins on chaperone function. We identified STI1/HOP-containing chaperone complexes that interact with ribosomal client proteins in an amastigote-specific manner. Genetic analysis of STI1/HOP phosphorylation sites in conditional sti1 −/− null mutant parasites revealed two phosphoserine residues essential for parasite viability. Phosphorylation of the major Leishmania chaperones at the pathogenic stage suggests that these proteins may be promising drug targets via inhibition of their respective protein kinases.
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signaling | stress response K inetoplastid parasites of the genus Leishmania generate a variety of pathologies collectively termed leishmaniasis, afflicting millions of people worldwide (1, 2) . During the infectious cycle, these insect-borne parasitic trypanosomatids are exposed to a temperature increase following transmission from the invertebrate to the vertebrate host. The temperature change provides a crucial signal for developmental transition of the promastigote insect form to the amastigote form that thrives inside host phagocytes, generating the disease (3) . Despite the relevance of heat-induced stage differentiation for pathogenesis, mechanisms underlying the parasite heat-shock response and its role in the development and survival of the amastigote stage remain poorly understood.
Trypanosomatids express highly conserved members of heatshock and chaperone protein families, suggesting that the cellular response to heat stress is similar between parasite and host (4, 5) . However, in contrast to other eukaryotes that regulate heat-induced expression of molecular chaperones and cytoprotective proteins via a family of heat-shock transcription factors (HSFs) (6) , trypanosomatid genomes do not encode for classical transacting nuclear factors (7) . Gene expression in these organisms relies on highly parasite-specific mechanisms involving polycistronic transcription and transsplicing (8, 9) . Expression of the major heat-shock proteins (HSPs) is constitutive, even if heat shock may induce a transient increase in synthesis, which has been shown to be regulated exclusively at the posttranscriptional level (10) (11) (12) (13) . In contrast to its vertebrate host, both constitutive and inducible expression of Leishmania HSPs occurs from the same set of genes, making constitutive and stress-inducible chaperones indistinguishable at the sequence level (11, 14) . This important difference in host and parasite biology raises questions concerning the role of Leishmania HSPs at low temperatures in promastigotes and regulation of their chaperone function upon temperature increase in differentiating and proliferating amastigotes. By combining approaches of quantitative phosphoproteomics, systems biology, and mutagenesis, we have uncovered several unique properties of Leishmania donovani HSPs with respect to protein modifications, complex formation, and the importance of chaperone phosphorylation in parasite viability.
Results and Discussion
Two-dimensional differential gel electrophoresis (2D-DIGE) analysis of affinity-enriched phosphoextracts obtained from L. donovani LD1S promastigotes and axenic amastigotes (15, 16) revealed dramatic differences in protein phosphorylation profiles across the major Leishmania infectious stages (Fig. 1A, Fig. S1B , and Dataset S1). A total of 831 protein spots were detected automatically using the DeCyder Differential Analysis Software Package (GE Healthcare), and >700 spots matched between three gels representing independent biological replicates, indicating little experimental variation between samples and highly reproducible two-dimensional gel electrophoresis (2DE) conditions (Dataset S1). A total of 171 proteins were identified by mass spectrometry using the genome database of highly related Leishmania infantum (WWW.GeneDB.org) (Fig. S1A and Dataset S1), including 55 putative phosphoproteins not identified in our previous study using fluorescent multiplex staining (17) . Gene ontology (GO) analysis of the Leishmania phosphoprotein dataset via yeast ortholog mapping (Dataset S2) identified six statistically significant GO categories that were overrepresented in our analysis (Fig. 1B and Table S1 ). Three of these processes-translation initiation, protein folding, and protein catabolism-have been implicated previously in trypanosomatid differential gene expression (9) , emphasizing the importance of protein phosphorylation in posttranslational control of this process.
We previously analyzed affinity-enriched L. donovani phosphoproteins by qualitative 2DE analysis and demonstrated the specificity of this procedure combining fluorescent phosphoprotein staining and phosphatase treatment (17) . In contrast to this analysis, which suggested only little stage-specific phosphorylation, the quantitative 2D-DIGE analysis revealed a statistically significant difference (P value <0.05) in protein abundance for 318 spots corresponding to 38% of the detected phosphoproteins, with 10.2% of the phosphoproteins showing a statistically significant increase in abundance at the amastigote stage of ≥2-fold ( Fig. S1B and Dataset S1). Significantly, amastigote phosphoproteins with increased abundance and thus phosphorylation compared to promastigotes were almost exclusively protein chaperones, including several isoforms of HSP90 family member HSP83 (hereafter referred to as HSP90), various HSP70 family members, stress-induced protein STI1/HOP (referred to hereafter as STI1) (18) , cyclophilin 40, and the L. donovani ortholog of tetratricopeptide repeat (TPR) domain-containing peptidylprolyl-isomerase-like protein LinJ19_V3.1560 ( Fig. 1C and Table S2 ). Previous proteomic studies that quantified changes in protein abundance during axenic amastigote differentiation ( Fig.  S2 ) (14) , along with quantitative Western blot analysis of promastigote and amastigote total and phosphoextracts ( Fig. 2A) , demonstrate that the expression of these protein chaperones across the promastigote and amastigote stages is largely constitutive and not induced by elevated temperature. The increased abundance of these HSPs and chaperones in the amastigote phosphoproteome therefore does not simply result from increased expression, but rather reflects a change in phosphorylation stoichiometry with, for example, an 8-fold increase in the phosphorylation ratio of STI1 at the intracellular stage ( Fig. 2A) .
Evidence for a potential regulatory role of HSP phosphorylation in Leishmania arises from MALDI-TOF/TOF mass spectrometry analysis of the phosphorylation sites of HSP90 and HSP70. Phosphopeptides were isolated after in-gel digestion and peptide extraction from the 2D gels by TiO 2 enrichment (Fig. 2B and Fig. S3A ). Manual analysis of the mass spectrometry spectra identified three phosphorylation sites at HSP90 Thr223 and Ser526 and at HSP70 Thr498. Conservation of the threonine residues between Leishmania and human HSP90 and HSP70 identifies this residue as a putative phosphorylation site in higher eukaryotes as well ( Fig. 2C and Fig. S3B ). Significantly, whereas the Thr223 residue in L. donovani HSP90 corresponds to serine in human HSP90 and thus may be regulated by phosphorylation, HSP90 Ser526 is unique to Leishmania despite the highly conserved sequence to the human homolog (Fig. 2C) . The presence . Enlarged regions of 2D-DIGE gels for Cy3-labeled promastigotes (pro, green) and Cy5-labeled amastigotes (ama, red), and the corresponding 3D views, are represented. The Bottom shows a graphic representation of differences in abundance of these proteins across three independent experiments. For normalization purposes, a Cy2-labeled internal standard was included, corresponding to a pool of protein from all extracts used in the analysis (st, standard).
of this phosphorylation site opens up the possibility that the function of this major HSP is regulated in a parasite-specific manner by changes in the protein ionic state through phosphorylation, which may affect protein conformation and interaction with other chaperones, thus adding new regulatory features to L. donovani HSP90. Whereas this phosphorylation site is conserved in Trypanosoma HSP90 as judged by multiple alignment (Fig. 2C) , this position is occupied in human and mouse HSP90 by aspartic acid. Thus, the HSP90 configuration in higher eukaryotes may be locked into a conformation that mimics constitutive phosphorylation. These findings indicate that regulation of HSP90 functions through posttranslational modifications may substantially differ between parasite and host despite the highly conserved sequence of this protein from Leishmania to man.
Biological network analysis using PathwayArchitect software applied to the identified parasite phosphoprotein datasets revealed the presence of a protein network formed between six amastigote phosphoproteins (Fig. 3A , Table S3 ). In other eukaryotes, this multimeric chaperone complex has been shown to provide an important signaling function through its interaction with so-called "client proteins," which include various steroid receptors and protein kinases (19, 20) . Cochaperone STI1 plays a crucial role in formation of this complex, acting as a scaffolding protein that mediates the interaction between HSP90 and the HSP70/client protein complexes through specific TPR-rich domains (21, 22) . We investigated the presence of the predicted STI1-containing protein complexes in Leishmania by Blue Native (BN) electrophoresis and Western blot analysis. Amastigotespecific phosphorylation of multiple protein chaperones correlated with the presence of numerous STI1-containing complexes ranging from 66 to 480 kDa (Fig. 3B) . As judged by coimmunoprecipitation using anti-STI1 antibody, only the amastigote STI1/HSP90 complex interacts with HSP70/client protein complexes (Fig. 3C ). Mass spectrometry analysis of the coprecipitated protein bands identified numerous client proteins implicated in the assembly of the protein translation machinery and the control of protein translation (Fig. 3D) . The specificity of this interaction has been controlled for by using an isotype-specific control antibody ( Fig. S3C ) and is further supported by the absence of client protein detection in promastigotes, despite their constitutive expression at both stages (23) . Our data correlate STI1 phosphorylation with complex formation linked to protein translation, which may affect resistance of ribosomal client proteins against proteasome-dependent degradation (24). Although we detected these complexes only in amastigotes, our data do not rule out the presence of similar complexes in promastigotes, which may have escaped our analysis due to their low abundance. These results are reminiscent of the observation that phosphorylation of murine STI1 affects localization of this protein and thus the types of client proteins that interact with STI1/ HSP90/HSP70 (25) .
We next used a genetic approach to investigate the biological significance of STI1 phosphorylation by mutagenesis. Three STI1 phospho-site mutants were generated on the basis of previously identified STI1 phosphoresidues in Trypanosoma brucei (26), mouse (27) , and human (28) (Fig. 4A) . As STI1 appears to be essential, we tested these mutants using a conditional knockout system (29) . In this approach, to guard against the lethal phenotype, both chromosomal STI1 alleles were inactivated in the presence of an episomal plasmid expressing WT STI1, yielding the mutant sti1 −/− /pXNG-STI1 ( Fig. 4B and Fig. S4 ). The episomal plasmid pXNG4SAT (29) additionally carries both a fluorescent (GFP) and a negative selectable thymidine kinase (TK) marker rendering parasites susceptible to the antiviral drug ganciclovir (GCV). Thus by FACS or drug selection sti1 −/ − /pXNG-STI1 parasites could be tested for their requirement to maintain the ectopic STI1 gene copy. The functionality of mutated STI1 genes was then tested in a "plasmid shuffle" (30) , by introducing a second plasmid, and asking whether the WT STI1 borne on pXNG could be lost. As expected for an essential gene, it was not possible to segregate away pXNG-STI1 in the chromosomal sti1 −/− null mutant, even in the presence of GCV ( This binary readout allowed us now to test for the functionality of the STI1 phosphorylation site mutants. The mutants were expressed in independent sti1 −/− /pXNG-STI1 clones, and their effect on negative selection against pXNG-STI1 was analyzed. Expression of the T217A mutant fully compensated for pXNG-STI1, which was efficiently eliminated during negative selection ( Fig. 4 C and D) . This result suggests that the T217A mutation does not affect the functional properties of STI1 (case 2, Fig.  4B ). In contrast, expression of neither S15A nor S481A was able to compensate for pXNG-STI1, which was maintained at levels comparable to the sti1 promastigote and amastigote stages (Fig. 4 C and D) . Together these data suggest that the STI1 residues S15 and S481 are essential phosphorylation sites (case 1, Fig. 4B ) required for L. donovani viability in culture and emphasize the importance of chaperone phosphorylation in parasite biology. Further analysis of the role of these phosphorylation sites in STI1 complex formation was precluded by the lethal sti1 −/− phenotype and the requirement to maintain WT STI1.
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The manner in which Leishmania regulates the response to stress is fundamentally different from that of other eukaryotes, including the mammalian host. In most organisms, stress-induced expression increases stress tolerance through protection of basic cell functions, without a major impact on cellular morphology and phenotype. In Leishmania, however, stress signals such as low pH and nutritional starvation, or high temperature, induce developmental programs that lead to differentiation of metacyclic promastigotes and amastigotes and adapt the parasite for transmission and intracellular survival (3, 31, 32) . This reinterpretation of the stress response likely translates into unique regulatory mechanisms and interactions of Leishmania chaperones. Our data provide important insights into these parasite-specific mechanisms, which may depend on (i) stage-specific chaperone phosphorylation during environmentally induced parasite differentiation; (ii) phosphorylation of unique residues in parasites HSP70, HSP90, and STI1; and (iii) formation of chaperone complexes. The emphasis on posttranslational regulation of the stress response in Leishmania through phosphorylation and other protein modifications may represent an evolutionary adaptation of trypanosomatid parasites to constitutive expression and the absence of transcriptional regulation (9) . By analogy to stress regulation through HSFs in other eukaryotes (33) , our data indicate that the absence of these factors in trypanosomatids may have been compensated for by the evolution of protein kinases that regulate chaperone function. In resting cells, HSF1 is inactivated in other eukaryotes through its association with HSP70 and HSP90, but is released and activated under stress conditions (34) . In a similar fashion, Leishmania chaperones may tether protein kinases that are released and activated during environmentally induced stage differentiation. Indeed, binding of Leishmania MAP kinases to HSP70 (35) and the direct implication of HSP90 in parasite differentiation established in geldanamycintreated parasites (36) suggest a unique model in which chaperone/ kinase interactions would regulate phosphotransferase activities, which in turn might directly feed back on chaperone functions and differentiation.
Materials and Methods
Cell Culture and Differentiation of L. donovani. The L. donovani strain 1S2D (MHOM/SD/62/1S-CL2D), clone LdB was cultured and axenic amastigotes were differentiated as described (16, 37) .
Preparation of L. donovani total and phosphoprotein extracts. Axenic promastigotes or axenic amastigotes 48 h after induction of differentiation by pH and temperature shift were harvested from logarithmic cultures. For phosphoprotein purification, protein concentration was adjusted to 0.1 mg/mL, and 2.5-mg extracts were applied onto equilibrated affinity columns of the phosphoprotein purification kit (Qiagen) according to manufacturer's instructions.
Western Blot Analysis. Proteins were revealed using the following antibodies: polyclonal anti-STI-1 (18) and anti-HSP83, mouse monoclonal anti-α-tubulin antibody (Sigma), and anti-rabbit or anti-mouse ZyMax Cy3 or Cy5 conjugated secondary antibodies (Invitrogen). In some experiments, NativePAGE Novex 4-16% Bis-Tris Gels (Invitrogen) were transferred onto PVDF membranes, and proteins were revealed using the antibodies described above and anti-rabbit HRP-conjugated secondary antibodies (Pierce).
Immunoprecipitation. Cells were lysed and incubated for 45 min at 4°C with STI-1 polyclonal antibody (10 μL, 200 μg/mL) and protein A MicroBeads (50 μL; Miltenyi Biotec). Mixtures were loaded on μMACS columns (Miltenyi Biotec). Eluates were separated by denaturing SDS/PAGE, gels were stained with SyproRuby, and bands of interest were excised and further analyzed by MS-MS/MS.
Blue Native PAGE. Native extracts were centrifuged at 20,000 × g for 30 min at 4°C. Twenty or 40 μg of protein, containing 0.025% Coomassie Blue G-250, were separated on NativePAGE Novex 4-16% Bis-Tris Gels (Invitrogen) at 150 V for 3 h and 250 V for 1 h at 4°C.
Sample Preparation and DIGE Labeling. Phosphoprotein pellets were resuspended inDIGEsamplebuffer(7M Urea, 2 M Thiourea, 4%CHAPS, 30mMTris, pH 8.5) to a final protein concentration of 5.0 mg/mL. Phosphoprotein extracts from promastigotes and amastigotes were differentially labeled with the spectrally resolvable Cy3 and Cy5, and a pool of both extracts was labeled with Cy2 for normalization purposes, following the manufacturer's recommendations (GE Healthcare). Three independent biological replicates of promastigote and amastigote phosphoextracts were prepared and resolved by 2D-DIGE. In addi- . Independent clones were transfected with episomal vector pLEXSY expressing either an additional copy of wild-type STI1 or one of the phospho-site mutants described in A. The ability of episomally expressed STI1 phospho-site mutants S15A, T217A, and S481A to complement for the loss of pXNG-STI1 during negative selection with gangciclovir (GCV) provides a genetic test to distinguish mutations that affect STI1 function (case 1, pXNG-STI1 is maintained) from silent mutations (case 2, pXNG-STI1 is lost). Selections were performed using 25 μg/mL puromycin, 150 μg/mL nourseothricin, 5 μg/mL bleomycin, and 50 μg/mL hygromycin B, respectively. BLEO, bleomycin resistance cassette; GCV, ganciclovir; GFP, green fluorescent protein gene; HYG, hygromycin B resistance cassette; PAC, puromycin resistance cassette; SAT, nourseothricin resistance cassette; TK, herpes simplex virus thymidine kinase gene. tion, a gel containing a pool of either pro-or amastigote extracts from all extractions was included for normalization purposes.
2DE.
A total of 90 μg of protein sample containing 30 μg of Cy3-and Cy5-labeled samples was pooled together with 30 μg of Cy2-labeled control and adjusted with 150 μL Destreak rehydration buffer (GE Healthcare) containing 0.5% IPG buffer 4-7 and 1.0% DTT. Samples were simultaneously separated in the first dimension by iso-electric focusing (IEF) overnight (see SI Materials and Methods for details).
Staining Procedures and Image Analysis. After electrophoresis, gels were scanned on a Typhoon 9410 Variable Mode Imager (GE Healthcare) and analyzed with DeCyder 6.5 software (GE Healthcare).
Protein Identification by Mass Spectrometry. Spots of interest were excised from gels using the ProPic Investigator robotic system (Genomic Solutions). MS and MS/MS raw data for protein identification were obtained as previously described (17) (see SI Materials and Methods for details).
Phosphopeptide Identification. Protein digests, obtained as described above, were diluted in loading buffer (80% ACN, 5% TFA) (38) and loaded on TiO 2 microcolumns as described previously (39 μL Destreak rehydration buffer (GE Healthcare) containing 0.5% IPG buffer 4-7 and 1.0% DTT. Samples were simultaneously separated in the first dimension by iso-electric focusing (IEF) overnight at 20°C using the gel-based IPGphor isoelectric focusing system (GE Healthcare) and 11-cm DryStrip (pH 4-7) immobiline strips. Strips were rehydrated overnight at room temperature in Destreak rehydratation solution containing 0.5% IPG Buffer 4-7 (GE Healthcare). Samples were applied to the acidic end of the strip using a sample cup. The maximun current setting was 50 μA/strip and the IEF run was carried out using the following conditions: 100-V gradient step for 5 h, 300-V gradient step for 5 h, 1,000-V gradient step for 2 h, 6,000-V gradient step for 8 h, and 6,000 V for 5 h (60,550 Vh). Following IEF, strips were sequentially incubated for 15 min in 6 M urea, 75 mM Tris/HCl (pH 8.8), 29.3% glycerol, 4% SDS, and 0.002% bromophenol blue supplemented with either 65 mM DTT or 13.5 mM iodoacetamide. The strips were transferred to SDS polyacrylamide gels and sealed with 0.5% agarose in 25 mM Tris-base, 0.19 M glycine, 0.2% SDS, 0.01% bromophenol blue. Electrophoresis was carried out in an Ettan DALT six electrophoresis system (GE Healthcare) using 12.5% SDS/PAGE gels and two-step runs (1 W/gel for 1 h and 13 W/gel for 6 h).
In some experiments, phosphoprotein extracts were subjected to dephosphorylation before 2DE analysis. Samples were incubated for 30 min at 30°C with 4,000 units of lambda protein phosphatase (New England BioLabs) in reaction buffer containing 50 mM Tris-HCl (pH 7.5), 0.1 mM EDTA, 5 mM DTT, 0.01% Brij, and 35.2 mM MnCl 2 .
Staining Procedures and Image Analysis. After electrophoresis, gels were scanned on a Typhoon 9410 Variable Mode Imager (GE Healthcare), using 488/520 nm for Cy2, 532/580 nm for Cy3, 633/ 670 nm for Cy5, and 100 μm as pixel size. Gel images were normalized by adjusting voltage to obtain appropriate pixel value without any saturation. Images were analyzed with DeCyder 6.5 software (GE Healthcare). Spot detection and quantification for each gel were carried out in a DeCyder Differential In-gel Analysis (DIA) module. The automatic spot detection settings were 1,500. After spot detection, spots located outside of the area of interest or nonproteinaceous spots corresponding to dust particles were excluded. Gels were matched in the DeCyder Biological Variation Analysis (BVA) module. A 1.5-fold difference in abundance, with a confidence of P values <0.05, was considered significant.
For MS analysis, gels were fixed in 50% methanol and 7% acetic acid, restained with SYPRO Ruby Staining (Invitrogen) overnight, and visualized on the Typhoon at 532/610 nm and 100 μm pixel size.
Protein Identification by Mass Spectrometry. Spots of interest were excised from gels using the ProPic Investigator robotic system (Genomic Solutions) and collected in 96-well plates. Destaining, reduction, alkylation, and trypsin digestion of the proteins followed by peptide extraction were carried out with the ProGest Investigator (Genomic Solutions).
After a desalting step using C18-μZipTip (Millipore), peptides were eluted directly using the ProMS Investigator (Genomic Solutions) onto a 96-well stainless steel MALDI target plate (Applied Biosystems/MDS SCIEX) with 0.5 μl of CHCA matrix (10 mg/mL in 70% ACN/30% H 2 O/0.1% TFA).
MS and MS/MS raw data for protein identification were obtained on the 4800 Proteomics Analyzer (Applied Biosystems) and analyzed by GPS Explorer 2.0 software (Applied Biosystems/ MDS SCIEX). For positive-ion reflector mode spectra 3,000 laser shots were averaged. For MS calibration, autolysis peaks of trypsin ([M + H] + = 842.5100 and 2,211.1046) were used as internal calibrates. Monoisotopic peak masses were automatically determined within the mass range 800-4,000 Da with a signal-tonoise ratio minimum set to 30. Up to 12 of the most intense ion signals were selected as precursors for MS/MS acquisition, excluding common trypsin autolysis peaks and matrix ion signals. In MS/MS positive ion mode, 4,000 spectra were averaged, collision energy was 2 kV, collision gas was air, and default calibration was set using the Glu 1 -Fibrino-peptide B ([M + H] + = 1,570.6696) spotted onto 14 positions of the MALDI target. Combined peptide mass fingerprint and MS/MS queries were performed using the MASCOT search engine 2.1 (Matrix Science) embedded into GPS-Explorer Software 3.5 (Applied Biosystems/MDS SCIEX) on the Leishmania major and Leishmania infantum databases (Gene DB) with the following parameter settings: 50 ppm mass accuracy, trypsin cleavage, one missed cleavage allowed, carbamidomethylation set as fixed modification, oxidation of methionines allowed as variable modification, and MS/MS fragment tolerance set to 0.3 Da. Protein hits with MASCOT protein score ≥50 and a GPS Explorer protein confidence index ≥95% were used for further manual validation.
Phosphopeptide Identification. Protein digests, obtained as described above, were diluted in loading buffer (80% ACN, 5% TFA) (1) and loaded on TiO 2 microcolumns as described previously (2). After two washing steps in 10 μL loading buffer and 60 μL buffer 2 (80% ACN, 1% TFA), phosphopeptides were eluted using 2 μL NH 4 OH (pH 12) onto the MALDI target. For crystallization, 0.8 μL of 20 g/L DHB dissolved in ACN, water, and phosphoric acid (50/44/6, vol/vol/vol) was added. All MS/MS raw spectra were externally calibrated and annotated as for classical protein identification. The L. major and L. infantum databases (Gene DB) were searched using MASCOT software with the following parameters: trypsin cleavage, two missed cleavage sites allowed, carbamidomethylation set as fixed modification, 110 ppm mass tolerance for MS, and 0.25 Da for MS/ MS fragment ions. Phosphorylation (STY) and Deamidation (NQ) were allowed as variable modifications. All phosphorylated peptides were first checked for the presence of the major fragment ion [MH-H 3 PO 4 ] + = MH − 98 Da corresponding to the loss of the phosphate moiety and identified positively by MAS-COT. In addition, all MS/MS spectra were carefully checked manually for assignment of phosphorylation sites. , clone 2, indicating that a wild-type allele was retained. 
